id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
ajlm-484	Jean Louis, Frantz; Huang, Jennifer Y.; Nebie, Yacouba K.; Koivogui, Lamine; Jayaraman, Gayatri; Abiola, Nadine; Vansteelandt, Amanda; Worrel, Mary C.; Shang, Judith; Murphy, Louise B.; Fitter, David L.; Marston, Barbara J.; Martel, Lise	Implementation of broad screening with Ebola rapid diagnostic tests in Forécariah, Guinea	2017		.htm	text/html	4509	200	44	The OraQuick® Ebola Rapid Antigen test (OraQuick® Ebola RDT; OraSure Technologies, Inc., Bethlehem, Pennsylvania, United States) received an Emergency Use Authorization from the US Food and Drug Administration in July 2015 for whole blood testing.5,6,7 The OraQuick® Ebola RDT has a manufacturer-reported sensitivity of 84% (95% confidence interval While all febrile patients should have been eligible for both malaria and Ebola RDT tests, most febrile patients had a malaria RDT done, but only about half of febrile patients were tested for EVD.	cache/ajlm-484.htm	txt/ajlm-484.txt